furosemide has been researched along with Cancer of Stomach in 3 studies
Furosemide: A benzoic-sulfonamide-furan. It is a diuretic with fast onset and short duration that is used for EDEMA and chronic RENAL INSUFFICIENCY.
furosemide : A chlorobenzoic acid that is 4-chlorobenzoic acid substituted by a (furan-2-ylmethyl)amino and a sulfamoyl group at position 2 and 5 respectively. It is a diuretic used in the treatment of congestive heart failure.
Excerpt | Relevance | Reference |
---|---|---|
"Furosemide use was not associated with reduced cancer-specific mortality overall (adjusted HR in esophageal cancer = 1." | 1.51 | Furosemide use and survival in patients with esophageal or gastric cancer: a population-based cohort study. ( Cardwell, CR; Coleman, HG; Johnston, BT; Liu, P; McMenamin, ÚC; Spence, AD, 2019) |
"FLP therapy for advanced or recurrent stomach cancer in outpatients was expected to improve the QOL." | 1.29 | [Effects of combination chemotherapy using 5-FU, leucovorin, and CDDP (FLP therapy) for noncurative resected or recurrent stomach cancer in outpatients]. ( Kobayashi, O; Motohashi, H; Okada, K; Okugawa, T; Onodera, S; Rino, Y; Sairenji, M, 1994) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Liu, P | 1 |
McMenamin, ÚC | 1 |
Spence, AD | 1 |
Johnston, BT | 1 |
Coleman, HG | 1 |
Cardwell, CR | 1 |
Shiozaki, A | 1 |
Miyazaki, H | 1 |
Niisato, N | 1 |
Nakahari, T | 1 |
Iwasaki, Y | 1 |
Itoi, H | 1 |
Ueda, Y | 1 |
Yamagishi, H | 1 |
Marunaka, Y | 1 |
Okugawa, T | 1 |
Onodera, S | 1 |
Rino, Y | 1 |
Okada, K | 1 |
Kobayashi, O | 1 |
Sairenji, M | 1 |
Motohashi, H | 1 |
3 other studies available for furosemide and Cancer of Stomach
Article | Year |
---|---|
Furosemide use and survival in patients with esophageal or gastric cancer: a population-based cohort study.
Topics: Aged; Aged, 80 and over; Diuretics; Esophageal Neoplasms; Female; Follow-Up Studies; Furosemide; Hum | 2019 |
Furosemide, a blocker of Na+/K+/2Cl- cotransporter, diminishes proliferation of poorly differentiated human gastric cancer cells by affecting G0/G1 state.
Topics: Adenocarcinoma; Cell Cycle; Cell Differentiation; Cell Line, Tumor; Cell Proliferation; Furosemide; | 2006 |
[Effects of combination chemotherapy using 5-FU, leucovorin, and CDDP (FLP therapy) for noncurative resected or recurrent stomach cancer in outpatients].
Topics: Adult; Aged; Ambulatory Care; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant | 1994 |